This NDA submission is an important milestone, and it brings gedatolisib one step closer to becoming available for patients with HR+/HER2- advanced breast cancer,” said Brian Sullivan, CEO and ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...

FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...

São Paulo imitated the defense used by Vitor Roque, a forward for Palmeiras, in an attempt to reach an agreement with the ...

São Paulo imitated the defense used by Vitor Roque, a forward from Palmeiras, in an attempt to reach an agreement with the ...

The exit polls came out after the conclusion of voting in Bihar. While the first phase of polls was held on November 6, the second phase of polling concluded on Tuesday. The state has seen record ...

Among the key constituencies, Supaul recorded a turnout of 31.10 per cent, Sasaram 29.84 per cent, Mohania 32.91 per cent, Kutumba 33.40 per cent, Gaya Town 25.02 per cent, Chainpur 32.31 per cent, ...

Q3 2025 Earnings Call Transcript November 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...

Q3 2025 Earnings Call November 17, 2025 8:30 AM ESTCompany ParticipantsMatthew Duffy - Chief Business Officer & ...

ADJUDICATOR’S JURISDICTION TO ORDER PAYMENT OF AN INTERIM APPLICATION NOTIFIED SUM WITHIN A TRUE VALUE ADJUDICATION- The ...

Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns SEATTLE and VANCOUVER, British ...

Best skincare products for rosacea, as approved by a rosacea sufferer and an expert. These products will reduce redness and ...